Follicle-stimulating hormone, is a hormone secreted by the anterior pituitary basophils, composed of glycoprotein. Major role for promoting follicular growth. Human follicular stimulating hormone promote membrana granulosa cell proliferation, differentiation, whole ovary grows up. On the testicular seminiferous tubules can promote the formation of sperm.
A hormone secreted by the anterior pituitary basophils, composed of glycoprotein. Major role for promoting follicular growth. Human follicular stimulating hormone promote membrana granulosa cell proliferation, differentiation, whole ovary grows up. On the testicular seminiferous tubules can promote the formation of sperm. Number of FSH injections only follicles, follicular would serve no purpose. Follicle-stimulating hormone secreted by the hypothalamus releases hormones that control the secretion of FSH. During the menstrual cycle, FSH in the blood concentrations and daily by the amount of FSH urine excretion vary with the cycle. After the menopause, FSH in the blood and urine excretion increased.
Secreted by the anterior pituitary basophil is a glycoprotein hormone, controlled by the hypothalamic gonadotropin-releasing hormone, its function is to promote follicular development, born in male germ tube formation and function. Primary ovarian follicular development and maturation. Serum FSH concentration in preovulatory 1.5~10mIU/ml, for 8~20mIU/ml the time of ovulation, late ovulation is 2~10mIU/ml. General 5~40mIU/ml as normal.
-
singclean | 2017-02-15Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2017-02-15Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen
-
singclean | 2017-02-15Singclean Medical Shines at WHX Kuala Lumpur 2025, IVD Solutions Garner Strong Attention Across ASEANKuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.